These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30788336)

  • 1. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.
    Elsayes KM; Kielar AZ; Chernyak V; Morshid A; Furlan A; Masch WR; Marks RM; Kamaya A; Do RKG; Kono Y; Fowler KJ; Tang A; Bashir MR; Hecht EM; Jambhekar K; Lyshchik A; Rodgers SK; Heiken JP; Kohli M; Fetzer DT; Wilson SR; Kassam Z; Mendiratta-Lala M; Singal AG; Lim CS; Cruite I; Lee J; Ash R; Mitchell DG; McInnes MDF; Sirlin CB
    J Hepatocell Carcinoma; 2019; 6():49-69. PubMed ID: 30788336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
    Elsayes KM; Kielar AZ; Elmohr MM; Chernyak V; Masch WR; Furlan A; Marks RM; Cruite I; Fowler KJ; Tang A; Bashir MR; Hecht EM; Kamaya A; Jambhekar K; Kamath A; Arora S; Bijan B; Ash R; Kassam Z; Chaudhry H; McGahan JP; Yacoub JH; McInnes M; Fung AW; Shanbhogue K; Lee J; Deshmukh S; Horvat N; Mitchell DG; Do RKG; Surabhi VR; Szklaruk J; Sirlin CB
    Abdom Radiol (NY); 2018 Oct; 43(10):2625-2642. PubMed ID: 30155697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LI-RADS: Past, Present, and Future, From the
    Marks RM; Masch WR; Chernyak V
    AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.
    Hu YX; Shen JX; Han J; Mao SY; Mao RS; Li Q; Li F; Guo ZX; Zhou JH
    Front Oncol; 2021; 11():641195. PubMed ID: 33912456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.
    Tang A; Singal AG; Mitchell DG; Hecht EM; Fowler KJ; Kulik L; Parikh ND; Kono Y; Sirlin CB
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1228-1238. PubMed ID: 30326302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.
    Wang H; Cao J; Fan H; Huang J; Zhang H; Ling W
    Quant Imaging Med Surg; 2023 Aug; 13(8):4919-4932. PubMed ID: 37581040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging diagnosis of hepatocellular carcinoma: LI-RADS.
    Cunha GM; Sirlin CB; Fowler KJ
    Chin Clin Oncol; 2021 Feb; 10(1):3. PubMed ID: 32527115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
    Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
    J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.
    Wilson SR; Lyshchik A; Piscaglia F; Cosgrove D; Jang HJ; Sirlin C; Dietrich CF; Kim TK; Willmann JK; Kono Y
    Abdom Radiol (NY); 2018 Jan; 43(1):127-142. PubMed ID: 28819825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    van der Pol CB; McInnes MDF; Salameh JP; Levis B; Chernyak V; Sirlin CB; Bashir MR; Allen BC; Burke LMB; Choi JY; Choi SH; Forner A; Fraum TJ; Giamperoli A; Jiang H; Joo I; Kang Z; Kierans AS; Kang HJ; Khatri G; Kim JH; Kim MJ; Kim SY; Kim YY; Kwon H; Lee JM; Lewis SC; McGinty KA; Mulazzani L; Park MS; Piscaglia F; Podgórska J; Reiner CS; Ronot M; Rosiak G; Song B; Song JS; Tang A; Terzi E; Wang J; Wang W; Wilson SR; Yokoo T
    Radiology; 2022 Feb; 302(2):326-335. PubMed ID: 34783596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LI-RADS Made Easy.
    Schima W; Kopf H; Eisenhuber E
    Rofo; 2023 Jun; 195(6):486-494. PubMed ID: 36724803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
    Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
    Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
    Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
    Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast-enhanced ultrasound: Liver Imaging Reporting and Data System (CEUS LI-RADS)].
    Dietrich CF; Potthoff A; Helmberger T; Ignee A; Willmann JK;
    Z Gastroenterol; 2018 May; 56(5):499-506. PubMed ID: 29734449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
    Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
    Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adoption of LI-RADS: a survey of non-academic radiologists.
    Marks RM; Fung A; Cruite I; Blevins K; Lalani T; Horvat N; Protopapas Z; Chaudhry H; Bijan B; Shiehmorteza M; Nepal P; Tang A
    Abdom Radiol (NY); 2023 Aug; 48(8):2514-2524. PubMed ID: 37233747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma.
    Lv K; Cao X; Dong Y; Geng D; Zhang J
    Ann Transl Med; 2021 Jul; 9(13):1076. PubMed ID: 34422988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.